Your browser doesn't support javascript.
loading
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.
Bernhard, Jürg; Luo, Weixiu; Ribi, Karin; Colleoni, Marco; Burstein, Harold J; Tondini, Carlo; Pinotti, Graziella; Spazzapan, Simon; Ruhstaller, Thomas; Puglisi, Fabio; Pavesi, Lorenzo; Parmar, Vani; Regan, Meredith M; Pagani, Olivia; Fleming, Gini F; Francis, Prudence A; Price, Karen N; Coates, Alan S; Gelber, Richard D; Goldhirsch, Aron; Walley, Barbara A.
Afiliação
  • Bernhard J; International Breast Cancer Study Group Coordinating Center and Bern University Hospital, Inselspital, Bern, Switzerland. Electronic address: juerg.bernhard@ibcsg.org.
  • Luo W; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ribi K; International Breast Cancer Study Group Coordinating Center, Bern, Switzerland.
  • Colleoni M; Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy.
  • Burstein HJ; Dana-Farber Cancer Institute and Alliance for Clinical Trials in Oncology, Boston, MA, USA.
  • Tondini C; Medical Oncology, Osp Papa Giovanni XXIII and International Breast Cancer Study Group, Bergamo, Italy.
  • Pinotti G; Medical Oncology, Ospedale di Circolo and Fondazione Macchi, and International Breast Cancer Study Group, Varese, Italy.
  • Spazzapan S; Medical Oncology, Centro di Riferimento Oncologico, and International Breast Cancer Study Group, Aviano, Italy.
  • Ruhstaller T; Breast Center, Kantonsspital St Gallen, Swiss Group for Clinical Cancer Research (SAKK), and International Breast Cancer Study Group, St Gallen, Switzerland.
  • Puglisi F; Department of Oncology, University Hospital of Udine, University of Udine and International Breast Cancer Study Group, Udine, Italy.
  • Pavesi L; Oncology Unit, Salvatore Maugeri Foundation, and International Breast Cancer Study Group, Pavia, Italy.
  • Parmar V; Surgical Oncology, Breast Services, Tata Memorial Hospital, and International Breast Cancer Study Group, Mumbai, India.
  • Regan MM; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Pagani O; Institute of Oncology of Southern Switzerland, Swiss Group for Clinical Cancer Research, and International Breast Cancer Study Group, Lugano Viganello, Switzerland.
  • Fleming GF; University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL, USA.
  • Francis PA; Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne and Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia, and International Breast Cancer Study Group.
  • Price KN; International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, Boston, MA, USA.
  • Coates AS; International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia.
  • Gelber RD; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, Frontier Science and Technology Research Foundation, Boston, MA, USA.
  • Goldhirsch A; Program for Breast Health (Senology), European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group, Bern, Switzerland.
  • Walley BA; Tom Baker Cancer Centre and National Cancer Institute of Canada Clinical Trials Group, Calgary, AB, Canada.
Lancet Oncol ; 16(7): 848-58, 2015 Jul.
Article em En | MEDLINE | ID: mdl-26092816
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ovário / Tamoxifeno / Neoplasias da Mama / Antineoplásicos Hormonais / Autorrelato Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ovário / Tamoxifeno / Neoplasias da Mama / Antineoplásicos Hormonais / Autorrelato Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article